In the SIV+ZIKV+ cohort, SIV viremia and peripheral CD4 counts remained stable post-ZIKV coinfection and there was no evidence of enhanced gut barrier dysfunction (Supplemental Figure 1C-E, 5A). Here, CD4 is linked to coinfection.